Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Andalan Sakti Primaindo Tbk (ASPI) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Andalan Sakti Primaindo TbkTrade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Andalan Sakti Primaindo Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Andalan Sakti Primaindo Tbk trades at Rp410 (market cap 280.36B, 170.8K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp165 (market cap 635.95B, 843K 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 2.3× Andalan Sakti Primaindo Tbk's market cap, and UBC Medical Indonesia Tbk. is more actively traded (843K versus 170.8K). Which is the better fit depends on your goals.

ASPILABS
Market Cap
280.36B635.95B
Volume
170.8K843K
Lot
1.71K8.43K
Turnover
70.08M137.6M
Average Price
410.28163.22
Value
70.08M137.6M
Indicative Equilibrium Price
410165
Indicative Equilibrium Volume
50246

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ASPI
View details
LABS
View details

About Andalan Sakti Primaindo Tbk

PT. Andalan Sakti Primaindo Tbk. ("the Company") was established based on the Notarial Deed of Saniwati Suganda, S.H., No.81 dated 13 November 2012. Entiry parent is PT Andalan Sakti Inti.

Read more on ASPI

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS